Francois Slabbert unpacks Namibia’s lack of Malaria treatment medication

[PODCAST]

NAMIBIA currently lacks the capacity to manufacture malaria treatment medication due to high costs and stringent international regulatory requirements.

This was confirmed by Fabupharm managing director Francois Slabbert, who said the pharmaceutical manufacturer discontinued its malaria drug production several years ago due to ineffectiveness and financial limitations.

 

Slabbert sat down with Daybreak to unpack this.